These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8902778)

  • 1. Antiphospholipid antibodies and atherosclerosis.
    Vaarala O
    Lupus; 1996 Oct; 5(5):442-7. PubMed ID: 8902778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to oxidised LDL.
    Vaarala O
    Lupus; 2000; 9(3):202-5. PubMed ID: 10805488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying 'membrane stress syndrome' hypothesis.
    Ames PR
    Lupus; 1994 Oct; 3(5):371-7. PubMed ID: 7841990
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiphospholipid antibodies and myocardial infarction.
    Vaarala O
    Lupus; 1998; 7 Suppl 2():S132-4. PubMed ID: 9814690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis?
    Sherer Y; Shoenfeld Y
    Immunobiology; 2003; 207(1):13-6. PubMed ID: 12638897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and atherosclerosis.
    Nicolo D; Monestier M
    Clin Immunol; 2004 Aug; 112(2):183-9. PubMed ID: 15240162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
    Barbui T; Finazzi G; Galli M
    Ann Ital Med Int; 1997; 12(2):76-83. PubMed ID: 9333316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non beta 2-glycoprotein I cofactors for antiphospholipid antibodies.
    Galli M
    Lupus; 1996 Oct; 5(5):388-92. PubMed ID: 8902767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis.
    Sherer Y; Shoenfeld Y
    Curr Atheroscler Rep; 2001 Jul; 3(4):328-33. PubMed ID: 11389799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein.
    Vaarala O; Puurunen M; Lukka M; Alfthan G; Leirisalo-Repo M; Aho K; Palosuo T
    Clin Exp Immunol; 1996 May; 104(2):269-74. PubMed ID: 8625519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
    Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
    Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity in atherosclerosis: lessons from experimental models.
    George J; Afek A; Gilburd B; Harats D; Shoenfeld Y
    Lupus; 2000; 9(3):223-7. PubMed ID: 10805492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody.
    Nicolo D; Goldman BI; Monestier M
    Arthritis Rheum; 2003 Oct; 48(10):2974-8. PubMed ID: 14558104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis and the antiphospholipid syndrome: a link unravelled?
    Shoenfeld Y; Harats D; George J
    Lupus; 1998; 7 Suppl 2():S140-3. PubMed ID: 9814692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis.
    Romero FI; Khamashta MA; Hughes GR
    Lupus; 2000; 9(3):206-9. PubMed ID: 10805489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.